Sandoz Inc. v. AbbVie Biotechnology Ltd > Summary
Court Case Number IPR2018-00156
Filing Date Nov 6, 2017
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesMichelle N. Ankenbrand, Tina E. Hulse, Susan L. C. Mitchell
Judge Writing the Final DecisionMichelle N. Ankenbrand
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Claims Instituted: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30
Petitioner
Patent Owner
Petitioner Attorneys
4Sandoz
Attorney Name: David R. Marsh
Arnold & Porter Kaye Scholer
Sandoz
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
Attorney Name: Deborah E. Fishman
Arnold & Porter Kaye Scholer
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
Patent Owner Attorneys
6AbbVie Biotechnology
Attorney Name: Jessica L. A. Marks
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: Maureen D. Queler
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: Michael J. Flibbert
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: William B. Raich
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: Pier D. Deroo
Finnegan, Henderson, Farabow, Garrett & Dunner
AbbVie Biotechnology
Attorney Name: William Esper
Finnegan, Henderson, Farabow, Garrett & Dunner
Related Patents
Doc No | Title | Issue date |
---|---|---|
09187559 | Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease | Nov 17, 2015 |